These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16526562)
1. Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy. Sziráki I; Horváth K; Bodor N Pharmazie; 2006 Feb; 61(2):140-3. PubMed ID: 16526562 [TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of a brain-enhanced chemical delivery system for estradiol. Rahimy MH; Simpkins JW; Bodor N Drug Des Deliv; 1990 May; 6(1):29-40. PubMed ID: 2078286 [TBL] [Abstract][Full Text] [Related]
3. New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox. Tapfer MK; Sebestyen L; Kurucz I; Horvath K; Szelenyi I; Bodor N Pharmacol Biochem Behav; 2004 Mar; 77(3):423-9. PubMed ID: 15006452 [TBL] [Abstract][Full Text] [Related]
4. 17 beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Rabbani O; Panickar KS; Rajakumar G; King MA; Bodor N; Meyer EM; Simpkins JW Exp Neurol; 1997 Jul; 146(1):179-86. PubMed ID: 9225751 [TBL] [Abstract][Full Text] [Related]
5. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation. Rahimy MH; Anderson WR; Brewster ME; Bodor N; Simpkins JW Endocrinology; 1991 Aug; 129(2):717-25. PubMed ID: 1855469 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting. Brewster ME; Druzgala PJ; Anderson WR; Huang MJ; Bodor N; Pop E J Pharm Sci; 1995 Jan; 84(1):38-43. PubMed ID: 7714741 [TBL] [Abstract][Full Text] [Related]
7. Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution. Rahimy MH; Simpkins JW; Bodor N Pharm Res; 1990 Oct; 7(10):1061-7. PubMed ID: 2281037 [TBL] [Abstract][Full Text] [Related]
8. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Anderson WR; Simpkins JW; Brewster ME; Bodor N Life Sci; 1988; 42(16):1493-502. PubMed ID: 3352462 [TBL] [Abstract][Full Text] [Related]
9. Pulsed estrogen therapy: from cellular mode of action to tissue effects. Al-Azzawi F Climacteric; 2002 Jun; 5 Suppl 2():27-31. PubMed ID: 12482108 [TBL] [Abstract][Full Text] [Related]
10. Effects of a brain-enhanced estrogen delivery system on tail-skin temperature of the rat: implications for menopausal hot flush. Rahimy MH; Bodor N; Simpkins JW Maturitas; 1991 Mar; 13(1):51-63. PubMed ID: 1907349 [TBL] [Abstract][Full Text] [Related]
11. A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system. Rahimy MH; Bodor N; Simpkins JW J Steroid Biochem; 1989 Aug; 33(2):179-87. PubMed ID: 2770295 [TBL] [Abstract][Full Text] [Related]
12. A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat. Estes KS; Keuth V; Dietzel K; Brewster ME; Bodor NS; Derendorf H Pharm Res; 1991 Sep; 8(9):1180-5. PubMed ID: 1788164 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system. Yiu S; Knaus EE J Med Chem; 1996 Nov; 39(23):4576-82. PubMed ID: 8917646 [TBL] [Abstract][Full Text] [Related]
14. A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. Estes KS; Brewster ME; Simpkins JW; Bodor N Life Sci; 1987 Mar; 40(13):1327-34. PubMed ID: 3561153 [TBL] [Abstract][Full Text] [Related]
15. Suppression of plasma testosterone and prostate carcinoma size by a redox-based, brain-targeted estrogen delivery system in the rat. Rahimy MH; Bodor N; Simpkins JW Prostate; 1993; 23(1):79-90. PubMed ID: 8337187 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats. Mullersman G; Derendorf H; Brewster ME; Estes KS; Bodor N Pharm Res; 1988 Mar; 5(3):172-7. PubMed ID: 3244629 [TBL] [Abstract][Full Text] [Related]
17. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus. Sahlin L; Masironi B; Akerberg S; Eriksson H Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620 [TBL] [Abstract][Full Text] [Related]
18. Lack of estradiol modulation of sleep deprivation-induced c-Fos in the rat brain. Mashoodh R; Stamp JA; Wilkinson M; Rusak B; Semba K Physiol Behav; 2008 Nov; 95(4):562-9. PubMed ID: 18761364 [TBL] [Abstract][Full Text] [Related]
19. Expression of prostatic glutathione-peroxidase (GSH-PO) in the rat treated with a combination of testosterone and 17beta-estradiol. Murakoshi M; Ikada R; Tagawa M Tokai J Exp Clin Med; 2003 Jul; 28(2):45-50. PubMed ID: 14714828 [TBL] [Abstract][Full Text] [Related]
20. Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Pluchino N; Merlini S; Cubeddu A; Giannini A; Bucci F; Casarosa E; Cela V; Angioni S; Luisi M; Genazzani AR Menopause; 2009; 16(5):1037-43. PubMed ID: 19295450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]